Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma

被引:11
作者
Vos, E. L. [1 ]
Carr, R. A. [2 ]
Hsu, M. [3 ]
Nakauchi, M. [1 ]
Nobel, T. [4 ]
Russo, A. [5 ]
Barbetta, A. [6 ]
Tan, K. S. [3 ]
Tang, L. [7 ,8 ]
Ilson, D. [9 ]
Ku, G. Y. [9 ]
Wu, A. J. [10 ]
Janjigian, Y. Y. [9 ]
Yoon, S. S. [1 ]
Bains, M. S. [2 ]
Jones, D. R. [2 ]
Coit, D. [1 ]
Molena, D. [2 ]
Strong, V. E. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Gastr & Mixed Tumor Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Bioinformat, New York, NY 10065 USA
[4] Mt Sinai Hlth Syst, Dept Surg, New York, NY USA
[5] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA USA
[6] Univ Southern Calif, Dept Surg, Los Angeles, CA 90007 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Pathol, Expt Pathol Serv, New York, NY 10065 USA
[8] Mem Sloan Kettering Canc Ctr, Dept Pathol, Gastrointestinal Pathol Serv, New York, NY 10065 USA
[9] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, New York, NY 10065 USA
[10] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA
来源
BJS-BRITISH JOURNAL OF SURGERY | 2021年 / 108卷 / 11期
基金
美国国家卫生研究院;
关键词
PREOPERATIVE CHEMORADIATION; PERIOPERATIVE CHEMOTHERAPY; ESOPHAGEAL; SURGERY; CANCER; CHEMORADIOTHERAPY; THERAPY;
D O I
10.1093/bjs/znab228
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Trials typically group cancers of the gastro-oesophageal junction (GOJ) with oesophageal or gastric cancer when studying neoadjuvant chemoradiation and perioperative chemotherapy, so the results may not be fully applicable to GOJ cancer. Because optimal neoadjuvant treatment for GOJ cancer remains controversial, outcomes with neoadjuvant chemoradiation versus chemotherapy for locally advanced GOJ adenocarcinoma were compared retrospectively. Methods: Data were collected from all patients who underwent neoadjuvant treatment followed by surgery for adenocarcinoma located at the GOJ at a single high-volume institution between 2002 and 2017. Postoperative major complications and mortality were compared between groups using Fisher's exact test. Overall survival (OS) and disease-free survival (DFS) were assessed by log rank test and multivariable Cox regression analyses. Cumulative incidence functions were used to estimate recurrence, and groups were compared using Gray's test. Results: Of 775 patients, 650 had neoadjuvant chemoradiation and 125 had chemotherapy. These groups were comparable in terms of clinical tumour and lymph node categories, although the chemoradiation group had greater proportions of white men, complete pathological response to chemotherapy, and smaller proportions of diffuse cancer, poor differentiation, and neurovascular invasion. Postoperative major complications (20.0 versus 17.6 per cent) and 30-day mortality (1.7 versus 1.6 per cent) were not significantly different between the chemoradiation and chemotherapy groups. After adjustment, type of therapy (chemoradiation versus chemotherapy) was not significantly associated with OS (hazard ratio (HR) 1.26, 95 per cent c.i. 0.96 to 1.67) or DFS (HR 1.27, 0.98 to 1.64). Type of recurrence (local, regional, or distant) did not differ after neoadjuvant chemoradiation versus chemotherapy. Conclusion: In patients undergoing surgical resection for locally advanced adenocarcinoma of the GOJ, OS and DFS did not differ significantly between patients who had neoadjuvant chemoradiation compared with chemotherapy.
引用
收藏
页码:1332 / 1340
页数:9
相关论文
共 33 条
[1]  
Ajani JA IH., 2017, AJCC CANC STAGING MA, P203, DOI DOI 10.1007/978-3-319-40618-3_17
[2]   Esophageal and Esophagogastric Junction Cancers, Version 2.2019 [J].
Ajani, Jaffer A. ;
D'Amico, Thomas A. ;
Bentrem, David J. ;
Chao, Joseph ;
Corvera, Carlos ;
Das, Prajnan ;
Denlinger, Crystal S. ;
Enzinger, Peter C. ;
Fanta, Paul ;
Farjah, Farhood ;
Gerdes, Hans ;
Gibson, Michael ;
Glasgow, Robert E. ;
Hayman, James A. ;
Hochwald, Steven ;
Hofstetter, Wayne L. ;
Ilson, David H. ;
Jaroszewski, Dawn ;
Johung, Kimberly L. ;
Keswani, Rajesh N. ;
Kleinberg, Lawrence R. ;
Leong, Stephen ;
Ly, Quan P. ;
Matkowskyj, Kristina A. ;
McNamara, Michael ;
Mulcahy, Mary F. ;
Paluri, Ravi K. ;
Park, Haeseong ;
Perry, Kyle A. ;
Pimiento, Jose ;
Poultsides, George A. ;
Roses, Robert ;
Strong, Vivian E. ;
Wiesner, Georgia ;
Willett, Christopher G. ;
Wright, Cameron D. ;
McMillian, Nicole R. ;
Pluchino, Lenora A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (07) :855-883
[3]   Gastric Cancer, Version 3.2016 [J].
Ajani, Jaffer A. ;
D'Amico, Thomas A. ;
Almhanna, Khaldoun ;
Bentrem, David J. ;
Chao, Joseph ;
Das, Prajnan ;
Denlinger, Crystal S. ;
Fanta, Paul ;
Farjah, Farhood ;
Fuchs, Charles S. ;
Gerdes, Hans ;
Gibson, Michael ;
Glasgow, Robert E. ;
Hayman, James A. ;
Hochwald, Steven ;
Hofstetter, Wayne L. ;
Ilson, David H. ;
Jaroszewski, Dawn ;
Johung, Kimberly L. ;
Keswani, Rajesh N. ;
Kleinberg, Lawrence R. ;
Korn, W. Michael ;
Leong, Stephen ;
Linn, Catherine ;
Lockhart, A. Craig ;
Ly, Quan P. ;
Mulcahy, Mary F. ;
Orringer, Mark B. ;
Perry, Kyle A. ;
Poultsides, George A. ;
Scott, Walter J. ;
Strong, Vivian E. ;
Washington, Mary Kay ;
Weksler, Benny ;
Willett, Christopher G. ;
Wright, Cameron D. ;
Zelman, Debra ;
McMillian, Nicole ;
Sundar, Hema .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (10) :1286-1312
[4]   Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].
Al-Batran, Salah-Eddin ;
Homann, Nils ;
Pauligk, Claudia ;
Goetze, Thorsten O. ;
Meiler, Johannes ;
Kasper, Stefan ;
Kopp, Hans-Georg ;
Mayer, Frank ;
Haag, Georg Martin ;
Luley, Kim ;
Lindig, Udo ;
Schmiegel, Wolff ;
Pohl, Michael ;
Stoehlmacher, Jan ;
Folprecht, Gunnar ;
Probst, Stephan ;
Prasnikar, Nicole ;
Fischbach, Wolfgang ;
Mahlberg, Rolf ;
Trojan, Joerg ;
Koenigsmann, Michael ;
Martens, Uwe M. ;
Thuss-Patience, Peter ;
Egger, Matthias ;
Block, Andreas ;
Heinemann, Volker ;
Illerhaus, Gerald ;
Moehler, Markus ;
Schenk, Michael ;
Kullmann, Frank ;
Behringer, Dirk M. ;
Heike, Michael ;
Pink, Daniel ;
Teschendorf, Christian ;
Loehr, Carmen ;
Bernhard, Helga ;
Schuch, Gunter ;
Rethwisch, Volker ;
von Weikersthal, Ludwig Fischer ;
Hartmann, Joerg T. ;
Kneba, Michael ;
Daum, Severin ;
Schulmann, Karsten ;
Weniger, Joerg ;
Belle, Sebastian ;
Gaiser, Timo ;
Oduncu, Fuat S. ;
Guentner, Martina ;
Hozaeel, Wael ;
Reichart, Alexander .
LANCET, 2019, 393 (10184) :1948-1957
[5]   Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer [J].
Allum, William H. ;
Stenning, Sally P. ;
Bancewicz, John ;
Clark, Peter I. ;
Langley, Ruth E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) :5062-5067
[6]  
Amin MB, 2017, AJCC cancer staging manual, P185, DOI [10.1007/978-3-319-40618-3_16, DOI 10.1007/978-3-319-40618-3]
[7]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[8]   Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial [J].
Burmeister, Bryan H. ;
Thomas, Janine M. ;
Burmeister, Elizabeth A. ;
Walpole, Euan T. ;
Harvey, Jennifer A. ;
Thomson, Damien B. ;
Barbour, Andrew P. ;
Gotley, David C. ;
Smithers, B. Mark .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (03) :354-360
[9]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[10]   Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma [J].
Gerber, N. ;
Ilson, D. H. ;
Wu, A. J. ;
Janjigian, Y. Y. ;
Kelsen, D. P. ;
Zheng, J. ;
Zhang, Z. ;
Bains, M. S. ;
Rizk, N. ;
Rusch, V. W. ;
Goodman, K. A. .
DISEASES OF THE ESOPHAGUS, 2014, 27 (03) :235-241